Is early induction or expectant management more beneficial in women with late preterm pre-eclampsia?

BMJ (Online)

Volumn 350, Issue , 2015, Pages

  Chappell, Lucy C ^a   Milne, Fiona ^b   Shennan, Andrew ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Action on Pre eclampsia Charity (APEC)   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; LABOR INDUCTION; LATE PRETERM PREECLAMPSIA; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN INTENSIVE CARE; NEWBORN MORBIDITY; PERINATAL DEATH; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; DELIVERY; EVIDENCE BASED MEDICINE; GESTATIONAL AGE; MORTALITY; NEWBORN; PATIENT EDUCATION; PRACTICE GUIDELINE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREMATURITY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME; UNITED KINGDOM;

DELIVERY, OBSTETRIC; EVIDENCE-BASED MEDICINE; FEMALE; GESTATIONAL AGE; GREAT BRITAIN; HUMANS; INFANT, NEWBORN; LABOR, INDUCED; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PREMATURE BIRTH; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84929497644     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.h191     Document Type: Article

References (15)

1. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010;376:631-44.
2. Flenady V, Koopmans L, Middleton P, Frøen JF, Smith GC, Gibbons K, et al. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet 2011;377:1331-40.
3. National Institute for Health and Clinical Excellence. Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. CG107, 2010. www.nice.org. uk/guidance/cg107
4. Churchill D, Duley L, Thornton JG, Jones L. Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks gestation. Cochrane Database Syst Rev 2013;7:CD003106.
5. Koopmans CM, Bijlenga D, Groen H, Vijgen SM, Aarnoudse JG, Bekedam DJ, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 2009;374:979-88.
6. Backes CH, Markham K, Moorehead P, Cordero L, Nankervis CA, Giannone PJ. Maternal preeclampsia and neonatal outcomes. J Pregnancy 2011;2011:214365.
7. Reddy UM, Ko CW, Raju TN, Willinger M. Delivery indications at late-preterm gestations and infant mortality rates in the United States. Pediatrics 2009;124:234-40.
8. Owens MY, Thigpen B, Parrish MR, Keiser SD, Sawardecker S, Wallace K, et al. Management of preeclampsia when diagnosed between 34-37 weeks gestation: deliver now or deliberate until 37 weeks? J Miss State Med Assoc 2014;7:208-11.
9. Broekhuijsen K, van Baaren G-J, van Pampus MG, Ganzevoort W, Sikkema M, Woiski MD, et al. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): a multicentre, open-label, randomised controlled trial. Lancet 2015; doi:10.1016/S0140-6736 (14) 61998-X, www.thelancet.com/journals/lancet/article/PIIS0140-6736 (14) 61998-X/abstract.
10. Langenveld J, Broekhuijsen K, van Baaren GJ, van Pampus MG, van Kaam AH, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial. BMC Pregnancy Childbirth 2011;11:50.
11. American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013;122:1122-31.
12. Myatt L, Redman CW, Staff AC, Hansson S, Wilson ML, Laivuori H, et al. Strategy for standardization of preeclampsia research study design. Hypertension 2014;63:1293-301.
13. Von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet 2011;377:219-27.
14. Action on Pre-eclampsia. www.action-on-pre-eclampsia.org.uk
15. The Preeclampsia Foundation. www.preeclampsia.org